Collider

About

Collider develops and sells non-alcoholic beer infused with adaptogens, nootropics and functional mushrooms, to provide a mood-boosting alternative to alcohol. Its beer is made using traditional ingredients and brewed in exactly the same way as alcoholic beer, but uses special strains of yeast and environmental control to ensure its alcohol content never goes above 0.5%. It's then infused with adaptopgens using a technique that ensures the flavour isn't impacted. Collider secured a raise of £720k in pre-seed funding in October, exceeding its target of 600k. It has seen very encouraging early sales, selling out six months' worth of product in just two months.